Variant report
Variant | esv2750773 |
---|---|
Chromosome Location | chr16:48830679-48831704 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180858404 | chr16:48830759-48830760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542301258 | chr16:48830785-48830786 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143434268 | chr16:48830799-48830800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374962725 | chr16:48830844-48830845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186150362 | chr16:48830864-48830865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147132399 | chr16:48830890-48830891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4344742 | chr16:48830919-48830920 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs544116334 | chr16:48830952-48830953 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563495011 | chr16:48830955-48830956 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529497311 | chr16:48830985-48830986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529455958 | chr16:48830992-48830993 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2058816 | chr16:48831015-48831016 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs67894444 | chr16:48831023-48831024 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11279602 | chr16:48831026-48831027 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374834509 | chr16:48831029-48831030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1420706 | chr16:48831032-48831033 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567862521 | chr16:48831066-48831067 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34768728 | chr16:48831108-48831109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527275152 | chr16:48831205-48831206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190955379 | chr16:48831221-48831222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369248184 | chr16:48831228-48831229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570444317 | chr16:48831303-48831304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539328205 | chr16:48831304-48831305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141024255 | chr16:48831372-48831373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545549453 | chr16:48831393-48831394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563850246 | chr16:48831397-48831398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535691566 | chr16:48831453-48831454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555873465 | chr16:48831495-48831496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533328774 | chr16:48831515-48831516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572606894 | chr16:48831601-48831602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs3103024 | chr16:48831611-48831612 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs557838050 | chr16:48831616-48831617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376823257 | chr16:48831648-48831649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546303539 | chr16:48831695-48831696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Disease | 22140031 | CNVD |
Non-syndromic sensorineural hearing loss | 22140031 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:48824600-48837600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr16:48829000-48831000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr16:48829200-48831400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr16:48829200-48831400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr16:48830000-48830800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
6 | chr16:48830000-48831200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr16:48830000-48831400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr16:48830600-48831000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr16:48830800-48831200 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr16:48831200-48833800 | Weak transcription | H1 Cell Line | embryonic stem cell |